Lepu Biopharma Schedules Critical Mid-Year Board Meeting

Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.

Lepu Biopharma Co., Ltd. has announced a Board meeting scheduled for August 21, 2024, to discuss and potentially approve the interim financial results for the first half of the year, consider an interim dividend, and address other business matters. This comes as a point of interest for investors who follow the company’s stock (Code: 2157) and are eager to learn about its performance and possible dividend announcements.

For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.